Prescrire International: Corporate influence over clinical research

Related PPRC Members: 
1 July 2012

Corporate influence over clinical research: considering the alternatives
Funding drug research independent of drug companies: a pipe dream or a public health necessity?

PPRC Member, Marc-André Gagnon, presents a case for independent funding of pharmacautical research in this Prescrire Outlook article published July 2012.